Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05917678

Effectiveness of Repositioning and Cranial Remolding in Infants With Cranial Deformation

This study will examine how effective caregiver's repositioning strategies are in correcting an infant's deformational cranial shape, as well as the effectiveness of the use of a custom cranial remolding orthosis for treatment of deformational head shapes. Infants with torticollis will be concurrently enrolled in physical therapy treatment until the torticollis is resolved. A normal, unaffected population will be studied to compare typical growth to the growth of infants undergoing active treatment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

2 month–3 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States

Location status: Recruiting

Location contact

Alex Kane, MD

SUB_INVESTIGATOR

Caitlin Deville, DSc

SUB_INVESTIGATOR

Jijia Wang, PhD

SUB_INVESTIGATOR

Rami Hallac, PhD

SUB_INVESTIGATOR

Susan Simpkins, EdD

SUB_INVESTIGATOR

Tiffany Graham, MSPO

CONTACT

[email protected]

214-645-8250

About this study

Infants 2 months of age who have been diagnosed with a deformational head shape will be begin repositioning therapy (and physical therapy if torticollis is present) and be followed at least monthly. At 4, 5, and 6 months of age, if the head shape has not resolved, they will be given the option to pursue treatment with a cranial remolding orthosis. All affected infants will undergo active treatment until the head shape is resolved or the infant is 12 months of age (whichever comes first).

Normal infants will be evaluated at 2, 6, and 12 months of age and will not be enrolled in any active treatment.

All infants will return at 12 months of age for a final evaluation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for Control Group:

  • Healthy infants with normal physical development and no need for physical therapy intervention

Exclusion criteria

for Control Group:

  • Infants with abnormal head shapes (plagiocephaly or craniosynostosis)
  • Infants with growth abnormalities (such as genetic conditions)
  • Infants with developmental delay significant to warrant physical therapy or occupational therapy

Treatment and study plan

Repositioning therapy

Other

Caregivers will be instructed how to increase tummy time activities and reshape their infant's heads using at-home methods to direct their attention to the non-preferred side.

Cranial Remolding Orthosis

Device

A custom cranial remolding orthosis (FDA Class II device) will be made to fit affected infants. this should be worn 23 hours per day and the Orthotist needs to be seen regularly for adjustments until the head shape is resolved.

Other names: Helmet, Cranial Band, STARband

Primary outcomes

  1. Final Head Shape

    Time frame: 10 months after enrollment (at 12 months of age)

    Cranial measurements will be used to assess residual cranial deformation in affected infants. A group of unaffected, typically-developing infants will be used as normal growth examples.

    Measurements include 2-dimensional measurements (taken at the greater equator of the skull with cranial calipers or a measuring tape): Cranial circumference, medio-lateral dimension of the skull, anterior-posterior dimension of the skull, two opposing diagonal measurements taken 30 degrees from the mid-sagittal line. These will be used to calculate the asymmetry and proportion of the skull and track growth.

    Measurements include 3-dimensional measurements: 1) An FDA-approved non-invasive, eye-safe laser scanner called the STARscanner will be used to track measurements throughout treatment. For those who switch to Cranial Remolding Therapy, this scanner will be used for custom helmet fabrication. 2) The 3dMD system will use photographs to create a 3-dimensional rendering of your child's head.

Secondary outcomes

  1. Overall Change in Head Shape

    Time frame: Assessment to occur within 2 years of enrollment closure.

    The improvements seen in each of the 2 treatment arms will be compared to determine if one treatment has a greater impact than the other treatment.

    Specifically, the difference between the baseline measurements (taken at 2 months of age) and the updated measurements (taken at each study measurement timepoint) will be compared in 2-dimensions and 3-dimensions. The group with greater correction to the cranial deformity would be considered the more impactful treatment method.

  2. Compliance with treatment

    Time frame: Assessment to occur within 2 years of enrollment closure.

    Overall compliance with each treatment method will be assessed.

    Caregivers of affected infants will be given surveys at each follow up appointment to assess adherence to the treatment arm's protocol. Surveys will include questions specific to the infant's treatment arm, which may include questions such as how long the child remains in a repositioned position before moving themselves, how many hours per day the infant is wearing their custom helmet, and how often caregivers are performing the recommended neck stretches.

    No surveys will be given to the typically-developing control group as there is no active treatment for this group.

Study contacts

Contact information is provided by the study sponsor or research team.

Tiffany Graham, MSPO

CONTACT

[email protected]

214-645-8250

Sponsors and collaborators

Lead sponsor

University of Texas Southwestern Medical Center

Other

Collaborators

  • Children's Health

Registry information

Official study title

Effectiveness of Repositioning, Physical Therapy, and Cranial Remolding in Infants With Cranial Deformation

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jun 26, 2023
Registry last updated
Aug 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.